* Newstin.com is for sale! * After achieving our strategic milestone, we are offering for sale: Newstin.com and all 14 related domains featuring 1 million unique visitors per month + continuously updated news database of 37 million articles in 12 world languages from 166,000 global and weighted sources + 2.1 billion metadata * To seize this unique chance, contact invest@newstin.com. * Newstin.com is for sale! *

Medtronic

New Data on Medtronic Limited's ENDEAVOR(R) Drug-Eluting Coronary Stent Shows Strong Performance...

biospace.com
9 hrs ago 3 related
        

WASHINGTON--(BUSINESS WIRE)--Medtronic, Inc. (NYSE:MDT - News), today released new data from the ENDEAVOR clinical program at the Transcatheter Cardiovascular Therapeutics (TCT) meeting that reinforces the consistently strong...

add comment
                   
startribune.com: startribune.com

Abbott, Boston Sci stents do equally well in heart study

startribune.com
7 hrs ago 5 related
        

Abbott Laboratories' Xience and Boston Scientific Corporation's Taxus Liberté, the newest entrants in the $1.9 billion U.S. market for heart stents, dueled to a tie in a study of heart attack victims. The two stents did equally...

add comment
                   

J&J Preview: The Doctor Is In (at CNBC)

yahoo.com
11 hrs ago 1 related
        

JOHNSON & JOHNSON (JNJ) Dow Component. Is generic competition taking a bigger-than-expected bite out of Risperdal sales? Johnson & Johnson's Cypher stent is facing stiff competition from Abbott Labs' Xience stent which just...

add comment
                   

Timothy Bays's profile changed

tudiabetes.com
9 hrs ago
        

Timothy Bays's profile changed 31 minutes ago left a comment for Timothy Bays Oct 10 Timothy Bays left a comment for Cody Turner Oct 10 Cody Turner left a comment for Timothy Bays Oct 9 Cody Turner left a comment for Timothy...

add comment
                   

Too Little Too Late for Boston Scientific (at Motley Fool)

yahoo.com
12 hrs ago 2 related
        

Imagine how well Boston Scientific (NYSE: BSX) could have done with a U.S. launch of its Taxus Liberte drug-eluting stent in 2005, as it was able to do in Europe. It would have had just one corporate competitor -- Johnson &...

add comment
                   

Foolish Forecast: J&J's Diversity Counts (at Motley Fool)

yahoo.com
12 hrs ago
        

Just like investors, well diversified companies like General Electric (NYSE: GE), Berkshire Hathaway (NYSE: BRK-A), and Johnson & Johnson (NYSE: JNJ) can take a hit in one area and keep on ticking. While Johnson & Johnson's...

add comment
                   

InvestSource, Inc.: China Medicine Corporation Chairman Discusses State of Company

tmcnet.com
yesterday 1 related
        

Stocks in the News: China Medicine Corporation (OTCBB: CHME), Heart Health, Inc. (PINKSHEETS: HHEL), CSMG Technologies, Inc., (OTCBB: CTGI), Cardima, Inc. (OTCBB: CADM) Oct 10, 2008 -- CSMG Technologies, Inc., (OTCBB: CTGI), a...

add comment
                   

Johnson & Johnson JNJ > Cordis awarded $1.2 Bln > final judgment against Medtronic and Boston...

ideasforsurgery.com
yesterday
        

Are Medtronic’s Microstent II, GFX and GFX II coronary stents no longer marketed or sold by Medtronic because they infringe the Palmaz and Schatz patents? Does the verdict not inhibit Medtronic from selling its currently...

add comment
genengnews.com: Genetic Engineering genengnews.com

Medtronic Announces Plans to Release Data on Broad Portfolio of Cardiovascular Innovations at TCT...

webwire.com
Oct 11, 2008 27 related
        

Two-Year Data from ENDEAVOR IV, Head-to-Head Comparison of Endeavor® and Taxus® Drug-Eluting Stents, Features Prominently in Tuesday's Late-Breaking Clinical Trials Session - - MINNEAPOLIS — Medtronic,... [WebWire - Saturday,...

add comment
                   

Andy Barnes's profile changed

tudiabetes.com
Oct 12, 2008 12 related
        

Most recent A1C (BG Average) Value What glucose meter do you use? Found you in the Deibetes Management A1C wooos/results On my way to the endo tomorrow think A1C will be up just like last time. He is more concerned about the...

add comment
1 2 3 4 5 next »